Abstract
The mitogenic response of T-cell subsets, the production of interleukin-1 (Il-1) and interleukin-2 (Il-2) and in vitro immunoglobulin production was investigated in patients with Hodgkin's disease (HD). The mitogenic response of mononuclear cells (MNC) and the OKT4+ and OKT8+ subsets was greatly reduced in advanced disease stages and could only partially be restored with exogeneous Il-2. In untreated patients with HD — except those with highly advanced disease — the OKT4+ lymphocytes showed normal response to phytohemagglutinin in contrast to the MNC suggesting inhibiting agents or cells within the MNC. These findings corresponded to reduced Il-2 synthesis of MNC, whereas isolated OKT4+ — cells produced normal or elevated amounts of Il-2. MNC or monocytes produced normal or even higher amounts of lipopolysaccharide-induced Il-1 than controls. The results do not confirm a defect in this component of the interleukin system in HD. The immunological impairment was not limited to the T-cell system but involved B-cell activation and differentiation as well. The pokeweed mitogen-induced IgM, IgG and IgG production was highly suppressed in untreated HD, whereas the MNC of previously treated patients produced subnormal amounts of immunoglobulin in vitro. It is not yet clear whether this defect is T-cell-mediated or primarily a B-cell deficiency.
Keywords: Advanced Disease, Disease Stage, Untreated Patient, Normal Response, Advanced Disease Stage
References
- Advani SH, D'Silva H, Gothoskar BP, Dinshaw KA, Nair NC, Gopalkrishna DR, Talwakar GV, Desai PB. Cellular immunity in Hodgkin's disease. Cancer. 1979;43:492. doi: 10.1002/1097-0142(197902)43:2<492::aid-cncr2820430214>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
- Bergmann L, Mitrou PS, Cherdron T, Holloway K, Jost J, Timm V, Zerth G. Expression of Ia-like antigen in lymphatic leukemias and non-Hodgkin's lymphomas in correlation with other surface markers. Scand J Haematol. 1982;29:224. doi: 10.1111/j.1600-0609.1982.tb00587.x. [DOI] [PubMed] [Google Scholar]
- Bergmann L, Mitrou PS, Kelker W, Weber KC. T-cell subsets in malignant lymphomas and monoclonal gammopathies. Scand J Haematol. 1985;34:170. doi: 10.1111/j.1600-0609.1985.tb02251.x. [DOI] [PubMed] [Google Scholar]
- Björgholm M, Wendelin C, Holm G, Johansson B, Mellstedt H. Longitudinal studies of blood lymphocyte capacity in Hodkin's disease. Cancer. 1981;48:2010. doi: 10.1002/1097-0142(19811101)48:9<2010::aid-cncr2820480917>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
- Björgholm M, Wendelin C, Holm G, Ogenstadt S, Johansson B, Mellstedt H. Immune status of untreated patients with Hodgkin's disease and prognosis. Cancer Treat Rep. 1982;66:701. [PubMed] [Google Scholar]
- Case DC, Hansen JA, Corrales E, Young CW, Dupont B, Pinsky CM, Good RA. Depressed in vitro lymphocyte responses to PHA in patients with Hodgkin's disease in continuous long remissions. Blood. 1977;49:771. [PubMed] [Google Scholar]
- Engleman EG, Benike C, Hoppe RT, Kaplan HS. Suppressor cells of the mixed lymphocyte reaction in patients with Hodgkin's disease. Transplant Proc. 1979;11:1827. [PubMed] [Google Scholar]
- Engval E, Perlaman P. Enzyme-linked immunoabsorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry. 1971;8:874. doi: 10.1016/0019-2791(71)90454-x. [DOI] [PubMed] [Google Scholar]
- Estevez ME, Ballart IJ, Diez RA, Sen L, Nicastro MA, Wechsler A. Normalization of monocyte candidacidal deficiency by cyclooxygenase inhibitors in Hodgkin's disease. Cancer. 1985;55:2774. doi: 10.1002/1097-0142(19850615)55:12<2774::aid-cncr2820551209>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
- Falkoff RJM, Muraguchi A, Hong J, Buller JL, Dinarillo CA, Fauci AS. The effects of interleukin 1 on human B cell activation and proliferation. J Immunol. 1983;131:801. [PubMed] [Google Scholar]
- Farrar RJM, Benjamin WR, Hilfiker ML, Howard M, Farr WL, Fuller-Farrer J. The biochemistry, biology and role of interleukin 2 in the induction of cytotoxic T cell antibody forming B cell responses. Immunol Rev. 1982;63:129. doi: 10.1111/j.1600-065x.1982.tb00414.x. [DOI] [PubMed] [Google Scholar]
- Fisher RI, Vanhaelen C, Bostick F. Increased sensitivity to normal adherent suppressor cells in untreated advanced Hodgkin's disease. Blood. 1981;57:830. [PubMed] [Google Scholar]
- Ford RJ, Tsao J, Kouttab NM, Saharabuddhe CG, Metha SR. Association of interleukin abnormality with the T-cell defect in Hodgkin's disease. Cancer. 1984;55:728. [PubMed] [Google Scholar]
- Forni M, Hofman FM, Parker JW, Lukes RJ, Taylor CR. B- and T-lymphocytes in Hodgkin's disease. Cancer. 1985;55:728. doi: 10.1002/1097-0142(19850215)55:4<728::aid-cncr2820550409>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
- Hillinger SM, Herzig GP. Impaired cell mediated immunity in Hodgkin's disease mediated by suppressor lymphocytes and monocytes. J Clin Invest. 1978;61:1620. doi: 10.1172/JCI109082. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Howard MK, Nakanishi K, Paul WE. B cell growth and differentiation factors. Immunol Rev. 1984;78:185. doi: 10.1111/j.1600-065x.1984.tb00482.x. [DOI] [PubMed] [Google Scholar]
- Kaye J, Gillis S, Mizel SB, Shevach EM, Malek TR, Dinarello CA, Lachmann LB, Janeway CA. Growth of a cloned helper T cell line induced by monoclonal antibody specific for the antigen receptor interleukin 1 is required for the expression of receptors for interleukin 2. J Immunol. 1984;133:1339. [PubMed] [Google Scholar]
- Miyawaki T, Nagaoki T, Yokoi T, Yachie A, Uwadana N, Taniguchi N. Cellular interactions of human T cell subsets defined by monoclonal antibodies in regulating B cell differentiation: A comparative study in Nocardia water-soluble mitogen and pokeweed mitogen-stimulated culture systems. J Immunol. 1982;128:899. [PubMed] [Google Scholar]
- Morimoto C, Todd RF, Distaso JA, Schlossman SF. The role of the macrophage in vitro primary anti-DNP antibody production of human interleukin 2. J Exp Med. 1981;155:943. [PubMed] [Google Scholar]
- Rappaport RS, Dodge GR. Prostaglandin E inhibits the production of human interleukin 2. J Exp Med. 1982;155:943. doi: 10.1084/jem.155.3.943. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Reinherz EL, Kung PC, Goldstein G, Schlossman SF. Separation of functional subsets of human T cells by a monoclonal antibody. Proc Natl Acad Sci. 1979;76:4061. [PubMed] [Google Scholar]
- Reinherz EL, Schlossman SF. Regulation of the immune response. Inducer and suppressor T-lymphocyte subsets in human beings. N Engl J Med. 1980;303:370. doi: 10.1056/NEJM198008143030704. [DOI] [PubMed] [Google Scholar]
- Reinherz EL, Morimoto C, Fitzgerald KA, Hussey RE, Daley JF, Schlossman SF. Heterogeneity of human T4 inducer cells defined by monoclonal antibody that delineates two functional subpopulations. J Immunol. 1982;128:463. [PubMed] [Google Scholar]
- Schulof RS, Lacher MJ, Gupta D. Abnormal phytohemagglutinin-induced T-cell proliferative response in Hodgkin's disease. Blood. 1981;57:607. [PubMed] [Google Scholar]
- Solbach W, Barth S, Röllinghoff M, Wagner H. Interactions of human T cell subsets during the induction of cytotoxic T lymphocytes: the role of interleukins. Clin Exp Immunol. 1982;49:167. [PMC free article] [PubMed] [Google Scholar]
- Thomas Y, Rogozinsky L, Irigoyen OH, Friedman SM, Kung PC, Goldstein G, Chess L. Functional subsets of human T cell subsets defined by monoclonal antibodies. Induction of suppressor cells within the OKT4 population. J Exp Med. 1981;154:459. doi: 10.1084/jem.154.2.459. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Welte K, Venuta S, Wang CY, Feldman SP, Ciobanu N, Kruger G, Feickert HJ, Merluzzi VJ, Flomenberg N, Moore MAS, Mertelsmann R. Human interleukin 2: Physiology, biochemistry, and pathophysiology in lymphoblastic leukemias and immunodeficiency syndromes. Haematol Blood Trans. 1983;28:369. doi: 10.1007/978-3-642-68761-7_72. [DOI] [PubMed] [Google Scholar]
- Young RC, Corder MP, Haynes HA, DeVita VZT. Delayed hypersensitivity in Hodgkin's disease. A study of 103 untreated patients. Am J Med. 1972;52:63. doi: 10.1016/0002-9343(72)90008-3. [DOI] [PubMed] [Google Scholar]
- Ziegler JB, Hansen P, Penny R. Intrinsic defect in Hodgkin's disease: Analysis of the phytohemagglutinin dose response. Clin Immunol Immunopathol. 1975;3:451. doi: 10.1016/0090-1229(75)90069-0. [DOI] [PubMed] [Google Scholar]